Swiss cancer drugs giant Roche (ROG: SIX) has acquired Signature Diagnostics, a privately-held company based in Potsdam, Germany. Financial terms of the transaction, which is the fifth deal in the past year aimed at building Roche’s molecular diagnostics business, were not disclosed.
{iframe}http://www.thepharmaletter.com/article/roche-acquires-germany-s-signature-diagnostics{/iframe}